Search for: "MCNEIL v. WYETH" Results 81 - 92 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Oct 2011, 4:58 am by Max Kennerly, Esq.
Consider those 2,200+ Reglan cases in Philadelphia: back in July, the Supreme Court’s decision in Pliva, Inc. v. [read post]
19 Sep 2013, 9:53 am by Bexis
Pfizer, Inc., 712 F.3d 21 (1st Cir. 2013), Aetna, Inc. v. [read post]
4 Mar 2012, 9:02 am by Schachtman
Wyeth, Inc., 500 F.Supp. 2d 1048, 1056-57 (S.D.Ill. 2007), aff’d, 556 F.3d 596 (7th Cir. 2009). [read post]
17 Sep 2009, 4:30 am
McNeil Laboratories, Inc., 807 F.2d 464 (5th Cir. 1987). [read post]
28 Jun 2007, 10:16 am
Wyeth-Ayerst Laboratories, 283 F.3d 315, 321 (5th Cir. 2002), and Williams v. [read post]
12 Sep 2014, 1:41 pm
Wyeth-Ayerst Labs., 385 F.3d 961, 965-966 (6th Cir. 2004); Bouchard v. [read post]
5 Jul 2008, 11:05 am
interview: (IP tango) Events 7 July: PLI briefing webcast ‘Life after Quanta v LGE: What every patent lawyer needs to know’: (PLI), 7-15 July/16-18 July: 2nd Transatlantic IP summer academy, modules one and two – Alicante/Milan: (IPKat), 9 July 2008: ALI & ABA webcast ‘Quanta v LG: What you should know’: (Patent Docs), 11 July: CIPA moot to improve participants’ understanding of procedures of EPO Technical… [read post]
25 Jan 2008, 1:00 am
: (Generic Pharmaceuticals & IP),Arava (Leflunomide) - Sanofi-Aventis loses bid to dismiss Louisiana Wholsesale Drug Co's antitrust claims accusing S-A of unlawfully blocking generic competition for Arava by filing a sham Citizen Petition with the USFDA: (IP Law360),Ciprofloxacin - CIPLA issued notice by National Pharmaceutical Pricing Authority for allegedly overpricing its antibiotic Ciprofloxacin (especially of note because CIPLA is objecting… [read post]